(Q36285161)

13 August 2017

1 reference

title

Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease? (English)

1 reference

13 August 2017

1 reference

Christian Mawrin

1

1 reference

13 August 2017

publication date

13 October 2005

1 reference

13 August 2017

published in

Acta Neuropathologica

1 reference

13 August 2017

volume

110

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

527-536

1 reference

Possible efficacy of temozolomide in a patient with gliomatosis cerebri

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-005-1083-8

Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-005-1083-8

Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-005-1083-8

Initial chemotherapy in gliomatosis cerebri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-005-1083-8

10.1007/S00401-005-1083-8

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference